|
Aug 6
|
Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook
|
|
Aug 6
|
COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised
|
|
Aug 6
|
Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Aug 6
|
CRL Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 View
|
|
Aug 6
|
Cencora raises annual profit forecast on strong demand for specialty drugs
|
|
Aug 6
|
Cencora (COR) Q3 Earnings and Revenues Surpass Estimates
|
|
Aug 6
|
Cencora’s (NYSE:COR) Q2 Sales Top Estimates
|
|
Aug 6
|
Cencora: Fiscal Q3 Earnings Snapshot
|
|
Aug 6
|
Cencora Reports Fiscal 2025 Third Quarter Results
|
|
Aug 6
|
Podcasting Impact: Unprecedented Press Coverage of All Three National Drug Wholesaler Conferences Supporting Independent Pharmacy
|
|
Aug 5
|
Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top
|
|
Aug 5
|
What To Expect From Cencora’s (COR) Q2 Earnings
|
|
Aug 4
|
Can Specialty and GLP-1 Momentum Support Cencora's Q3 Results?
|
|
Aug 4
|
DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?
|
|
Aug 4
|
Zimmer Biomet to Report Q2 Earnings: Here's What to Expect
|
|
Aug 4
|
Mallinckrodt Names Leslie Donato to Board of Directors
|
|
Aug 1
|
Gear Up for Cencora (COR) Q3 Earnings: Wall Street Estimates for Key Metrics
|
|
Aug 1
|
Will Healthcare Growth Help STE Beat on Q1 Earnings?
|
|
Aug 1
|
SYK Stock Falls Despite Q2 Earnings & Sales Beat, '25 View Up
|
|
Jul 31
|
BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down
|